325 related articles for article (PubMed ID: 33824803)
1. Mucinous Breast Carcinoma: Clinicopathological Comparison With Invasive Ductal Carcinoma.
Hashmi AA; Zia S; Yaqeen SR; Ahmed O; Asghar IA; Islam S; Afzal A; Irfan M; Zia F; Ali J
Cureus; 2021 Mar; 13(3):e13650. PubMed ID: 33824803
[TBL] [Abstract][Full Text] [Related]
2. Invasive Papillary Carcinoma of the Breast: Clinicopathological Features and Hormone Receptor Profile.
Hashmi AA; Munawar S; Rehman N; Ahmed O; Islam S; Asghar IA; Afzal A; Irfan M; Shamail F; Ali SJ
Cureus; 2021 Feb; 13(2):e13480. PubMed ID: 33777568
[TBL] [Abstract][Full Text] [Related]
3. Encapsulated Papillary Carcinoma of Breast: Clinicopathological Features and Prognostic Parameters.
Hashmi AA; Iftikhar SN; Munawar S; Shah A; Irfan M; Ali J
Cureus; 2020 Oct; 12(10):e11282. PubMed ID: 33274157
[TBL] [Abstract][Full Text] [Related]
4. Solid Papillary Carcinoma of Breast: Clinicopathologic Comparison With Conventional Ductal Carcinoma of Breast.
Hashmi AA; Iftikhar SN; Haider R; Haider R; Irfan M; Ali J
Cureus; 2020 Oct; 12(10):e11172. PubMed ID: 33262909
[TBL] [Abstract][Full Text] [Related]
5. Metaplastic Breast Carcinoma: Clinicopathological Parameters and Prognostic Profile.
Haroon S; Zia S; Shirazi UA; Ahmed O; Asghar IA; Diwan MA; Afzal A; Irfan M; Ali SJ; Hashmi AA
Cureus; 2021 Apr; 13(4):e14347. PubMed ID: 33987039
[TBL] [Abstract][Full Text] [Related]
6. Triple-Negative Metaplastic Breast Carcinoma: Association of Epidermal Growth Factor Receptor Expression With Prognostic Parameters and Clinical Outcome.
Munawar S; Haider R; Ali SM; Yaqeen SR; Islam S; Asghar IA; Afzal A; Zia S; Irfan M; Hashmi AA
Cureus; 2021 May; 13(5):e15006. PubMed ID: 34150374
[TBL] [Abstract][Full Text] [Related]
7. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
[TBL] [Abstract][Full Text] [Related]
8. Luminal B, Human Epidermal Growth Factor Receptor 2 (HER2/neu), and Triple-Negative Breast Cancers Associated With a Better Chemotherapy Response Than Luminal A Breast Cancers in Postneoadjuvant Settings.
Hashmi AA; Bukhari U; Najam J; Dowlah T; Ali AH; Diwan MA; Anjali F; Sham S; Zia S; Irfan M
Cureus; 2023 Jun; 15(6):e40066. PubMed ID: 37425505
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study.
Lei L; Yu X; Chen B; Chen Z; Wang X
PLoS One; 2016; 11(5):e0155132. PubMed ID: 27232881
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Expression Of Matrix Metalloproteinase-1 (MMP-1) in Different Types Of Breast Carcinoma And Its Comparison With ER/PER and HER2/neu.
Shamsi FB; Anwar A; Lail RA; Bukhari MH; Naseem N; Nagi AH
J Ayub Med Coll Abbottabad; 2022; 34(1):12-16. PubMed ID: 35466619
[TBL] [Abstract][Full Text] [Related]
12. The hormone receptor status in breast cancer and the relationship of subtypes with clinicopathological features.
Senel F
Indian J Pathol Microbiol; 2021; 64(4):671-676. PubMed ID: 34673584
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Immunohistochemical Profile of Breast Cancer for Prognostics and Therapeutic Use.
Chand P; Garg A; Singla V; Rani N
Niger J Surg; 2018; 24(2):100-106. PubMed ID: 30283220
[TBL] [Abstract][Full Text] [Related]
14. Estrogen and Progesterone Receptor Expression in Breast Carcinoma and Its Association With Clinicopathological Variables Among the Pakistani Population.
Sohail SK; Sarfraz R; Imran M; Kamran M; Qamar S
Cureus; 2020 Aug; 12(8):e9751. PubMed ID: 32944466
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.
Truin W; Roumen RMH; Siesling S; van de Vijver KK; Tjan-Heijnen VCG; Voogd AC
Breast Cancer Res Treat; 2017 Jul; 164(1):133-138. PubMed ID: 28365833
[TBL] [Abstract][Full Text] [Related]
16. Invasive Ductal Carcinoma Breast: How Neoadjuvant Chemotherapy Affects the Status of Estrogen Receptor, Progesterone Receptor and HER2/Neu-A Tertiary Care Centre Study.
Shubham S; Maan P; Singh M; Bhardwaj M
J Clin Diagn Res; 2017 Jul; 11(7):EC06-EC08. PubMed ID: 28892901
[TBL] [Abstract][Full Text] [Related]
17. Mucinous carcinoma of the breast in comparison with invasive ductal carcinoma: clinicopathologic characteristics and prognosis.
Bae SY; Choi MY; Cho DH; Lee JE; Nam SJ; Yang JH
J Breast Cancer; 2011 Dec; 14(4):308-13. PubMed ID: 22323918
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and genomic features of breast mucinous carcinoma.
Lu K; Wang X; Zhang W; Ye H; Lao L; Zhou X; Yao S; Lv F
Breast; 2020 Oct; 53():130-137. PubMed ID: 32781417
[TBL] [Abstract][Full Text] [Related]
19. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.
Inoue M; Nakagomi H; Nakada H; Furuya K; Ikegame K; Watanabe H; Omata M; Oyama T
Breast Cancer; 2017 Sep; 24(5):667-672. PubMed ID: 28108967
[TBL] [Abstract][Full Text] [Related]
20. Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients.
Elkablawy MA; Albasri AM; Mohammed RA; Hussainy AS; Nouh MM; Alhujaily AS
Saudi Med J; 2016 Feb; 37(2):137-41. PubMed ID: 26837394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
